Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.079 AUD | -1.25% | -3.66% | -41.48% |
Apr. 24 | Rhythm Biosciences Appoints CEO; Shares Down 3% | MT |
Mar. 21 | Rhythm Biosciences Receives AU$2.5 Million Under Rights Issue; Shares Up 3% | MT |
Sales 2022 | 2.43 3.68 | Sales 2023 | 3.1 4.69 | Capitalization | 90.11M 137M |
---|---|---|---|---|---|
Net income 2022 | -8M -12.12M | Net income 2023 | -8M -12.12M | EV / Sales 2022 | 98,363,837 x |
Net cash position 2022 | 7.43M 11.25M | Net cash position 2023 | 4.08M 6.19M | EV / Sales 2023 | 27,789,011 x |
P/E ratio 2022 |
-27.4
x | P/E ratio 2023 |
-10.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.75% |
1 day | -1.25% | ||
1 week | -3.66% | ||
Current month | -3.66% | ||
1 month | -15.05% | ||
3 months | -36.80% | ||
6 months | -59.49% | ||
Current year | -41.48% |
Managers | Title | Age | Since |
---|---|---|---|
Darren Moulton
COO | Chief Operating Officer | - | - |
Trevor Lockett
BRD | Director/Board Member | - | 17-05-31 |
Guy Carisbrooke
AUD | Comptroller/Controller/Auditor | - | 23-09-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Otto Buttula
CHM | Chairman | - | 19-10-27 |
Louis Panaccio
BRD | Director/Board Member | 67 | 17-07-31 |
Susan MacLeman
BRD | Director/Board Member | - | 23-01-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.079 | -1.25% | 283,731 |
24-05-09 | 0.08 | -1.23% | 27,272 |
24-05-08 | 0.081 | 0.00% | 66,289 |
24-05-07 | 0.081 | -1.22% | 147,366 |
24-05-06 | 0.082 | 0.00% | 44,199 |
Delayed Quote Australian S.E., May 10, 2024 at 01:59 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.48% | 12.83M | |
-27.67% | 9.87B | |
+34.87% | 3.07B | |
-17.30% | 2.73B | |
-11.15% | 2.24B | |
-22.32% | 1.63B | |
+23.58% | 771M | |
-1.31% | 760M | |
-28.57% | 516M | |
+5.37% | 310M |
- Stock Market
- Equities
- RHY Stock